ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag coronary heart disease disease medicine evolution

Coronary Disease
The Scientist Staff | Jun 7, 1998 | 4 min read
POSITIVE REDUCTION: Frank M. Sacks (left) of Brigham and Women's Hospital and Harvard University led a study that demonstrated that lowering cholesterol in patients from average to low levels significantly reduced the number of recurrent coronary events. The research team also included Lemuel A. Moye (right) of the University of Texas School of Public Health in Houston. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M.O. Arnold, C.C. W
Heart Disease
The Scientist Staff | Sep 26, 1999 | 3 min read
Edited by: Eugene Russo P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men," New England Journal of Medicine, 336:973-9, April 3, 1997. (Cited in more than 250 papers since publication) Comments by Paul M. Ridker, associate professor of medicine, Brigham and Women's Hospital, Boston Physicians typically check patients for signs of cardiovascular disease, or atherosclerosis, by measuring
a spiny mouse sits on a piece of wood holding a small morsel to its mouth
Spiny Mice Appear to Regenerate Damaged Kidneys
Dan Robitzski | Nov 3, 2021 | 5 min read
The mice, already known to regenerate skin, seem to avoid the tissue scarring that leads to organ failure in other animals.
Mutation Tied to Reduced Heart Disease
Kerry Grens | Jun 20, 2014 | 2 min read
Genetic variants that cripple a triglyceride-producing protein are linked with a lower risk of heart attack and stroke.
FDA Approves Oral Drug for Fabry Disease
Ashley Yeager | Aug 13, 2018 | 2 min read
The medicine increases the activity of a deficient enzyme in certain patients with the condition.
PCSK9 Drug Reduces Heart Disease Risk
Diana Kwon | Mar 21, 2017 | 2 min read
A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?
Trans Fats Linked to Heart Disease, Early Death
Kerry Grens | Aug 14, 2015 | 2 min read
The consumption of trans fats is tied to a higher chance of disease and dying sooner, according to a systematic review.
A blood test tube with the label ‘cfDNA Screening–Test’, held in a hand wearing blue gloves.
The Basics and Applications of Cell-Free DNA 
Rebecca Roberts, PhD | Nov 8, 2023 | 5 min read
Found circulating in peripheral blood, scientists use cell-free DNA (cfDNA) to assess genetic abnormalities, infections, cancer, transplant rejection, and cardiovascular disease.
Medicine
The Scientist Staff | May 10, 1992 | 2 min read
G. Brown, J.J. Albers, L.D. Fisher, S.M. Schaefer, et al., "Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipopro-tein B," New England Journal of Medicine, 323:1289-98, 1990. Greg Brown (University of Washington Medical Center, Seattle): "We have long known that cholesterol-loaded arteries in experimental animals will improve under conditions of low blood cholesterol; and clinical studies have been completed showing that red
The Heart of the Matter
Terry S. Elton, Mahmood Khan, and Dmitry Terentyev | Apr 1, 2011 | 4 min read
By Terry S. Elton, Mahmood Khan, and Dmitry Terentyev The Heart of the Matter Are miRNAs useful for tracking and treating cardiovascular disease? 3D4Medical / Photo Researchers, Inc. Rapid and accurate diagnosis of heart attacks—and the assessment of damage—is critical for improving coronary care. Mature microRNAs (miRNAs) are abundant, easily measured, and relatively stable in blood plasma. If they prove indicative of disease states, miRNAs meas

Run a Search

ADVERTISEMENT